thiazoles has been researched along with Adrenocortical Carcinoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caron-Beaudoin, E; Hudon-Thibeault, AA; Sanderson, JT; Vaillancourt, C; Viau, R | 1 |
Benhida, R; Doghman-Bouguerra, M; Lalli, E; Rocchi, S; Ronco, C; Ruggiero, C | 1 |
Avena, P; Campana, C; Cappello, AR; Casaburi, I; Chimento, A; De Luca, A; Domanico, F; Fiorillo, M; Lisanti, MP; Malivindi, R; Pezzi, V; Rago, V; Sirianni, R; Sotgia, F | 1 |
Caron-Beaudoin, É; Denison, MS; Sanderson, JT | 1 |
4 other study(ies) available for thiazoles and Adrenocortical Carcinoma
Article | Year |
---|---|
The use of a unique co-culture model of fetoplacental steroidogenesis as a screening tool for endocrine disruptors: The effects of neonicotinoids on aromatase activity and hormone production.
Topics: Adrenocortical Carcinoma; Aromatase; Cell Line, Tumor; Choriocarcinoma; Coculture Techniques; Cytochrome P-450 CYP3A; Endocrine Disruptors; Estradiol; Estrogens; Estrone; Female; Gene Expression Regulation; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Oxazines; Placenta; Pregnancy; Pyridines; Thiamethoxam; Thiazines; Thiazoles; Uterine Neoplasms | 2017 |
The GRP78/BiP inhibitor HA15 synergizes with mitotane action against adrenocortical carcinoma cells through convergent activation of ER stress pathways.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol; Dehydroepiandrosterone Sulfate; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Humans; Hydrocortisone; Mitotane; Sulfonamides; Thiazoles | 2018 |
Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC).
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Antineoplastic Agents, Hormonal; Autophagy; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Partial Agonism; Energy Metabolism; ERRalpha Estrogen-Related Receptor; G1 Phase Cell Cycle Checkpoints; Humans; Mice, Nude; Mitochondria; Molecular Targeted Therapy; Necrosis; Nitriles; Receptors, Estrogen; Signal Transduction; Thiazoles; Time Factors; Xenograft Model Antitumor Assays | 2015 |
Effects of Neonicotinoids on Promoter-Specific Expression and Activity of Aromatase (CYP19) in Human Adrenocortical Carcinoma (H295R) and Primary Umbilical Vein Endothelial (HUVEC) Cells.
Topics: Adrenocortical Carcinoma; Aromatase; Atrazine; Cell Line, Tumor; Dose-Response Relationship, Drug; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Oxazines; Promoter Regions, Genetic; Pyridines; Thiamethoxam; Thiazines; Thiazoles | 2016 |